Skip to content

Pioneering a new approach to biological discovery

IPI blends academic exploration with industrial scalability
to tap the full potential of recombinant antibodies.

"Lighting Up Neurobiology with Antibodies" promotional image.
"Lighting Up Neurobiology with Antibodies" promotional image.
"Anti-Integrin antibodies" promotional image.

IPI in brief

Drawing Of Microscope.

Meeting research needs

IPI scientists deploy cutting-edge technologies and techniques, such as antibody engineering and a yeast display library, to tap the full potential of synthetic recombinant antibodies.

Basic Drawing Of Antibody.

Best of both worlds

IPI combines deep academic expertise with industrial scalability, investing in high-throughput technologies and automation to bring biological research up to speed.

Figure Representing Business Model.

Unique business model

IPI is a nonprofit institute with assured funding and the high-caliber expertise to support exploratory protein research.

Drawing Of Lightbulb.

Cross-disciplinary connections

IPI is poised to elevate life science communities, collaborating with biologists across specialties and training young scientists.

Building collaborations

IPI believes the best science crosses fields. We draw together multiple disciplines to build antigen and antibody tools for basic biological research and therapeutic discovery.

News from the lab

IPI’s community-centered approach to antibody discovery: A Q&A with Rob Meijers

This spring, the Institute for Protein Innovation (IPI) dispatched a collection of antibodies targeting members of the elusive integrin receptor family. Those antibodies, shared with researchers...

Read more

Cell signaling, Sonic Hedgehog and Hemingway’s cats: A Q&A with Adrian Salic

In 1980, the famous geneticists Christiane Nüsslein-Volhard and Eric Wieschaus were mapping embryonic mutations in the model organism Drosophila melanogaster, known colloquially as the fruit fly....

Read more

IPI antibody helps illuminate the MYCN-mediated tumor microenvironment

If you were diagnosed with aggressive neuroblastoma, you’d most likely be an infant carrying a genetic change that sprang up in your nerve cells before you...

Read more
“A wise man always keeps learning”: Biotech entrepreneur Rusty Williams joins IPI Board

“A wise man always keeps learning”: Biotech entrepreneur Rusty Williams joins IPI Board

In 1984, Lewis “Rusty” Williams boarded a flight from Boston to San Francisco and took the last open seat near the back of the plane. Williams,...

Read more

Get in touch today

Back To Top